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Perinatal maternal depression and cortisol
function in pregnancy and the postpartum
period: a systematic literature review
Sunaina Seth1, Andrew J. Lewis2,5* and Megan Galbally2,3,4,5
Abstract
Background: Perinatal depression has a significant impact on both mother and child. However, the influence of
hormonal changes during pregnancy and the postpartum period remains unclear. This article provides a systematic
review of studies examining the effects of maternal cortisol function on perinatal depression.
Method: A systematic search was conducted of six electronic databases for published research on the relationship
between cortisol and perinatal depression. The databases included; MEDLINE complete, PsychINFO, SCOPUS, Psychology
and Behavioural Sciences, Science Direct and EBSCO, for the years 1960 to May 2015. Risk of bias was assessed and data
extraction verified by two investigators.
Results: In total, 47 studies met criteria and studies showed considerable variation in terms of methodology including
sample size, cortisol assays, cortisol substrates, sampling processes and outcome measures. Those studies identified as
higher quality found that the cortisol awakening response is positively associated with momentary mood states but is
blunted in cases of major maternal depression. Furthermore, results indicate that hypercortisolemia is linked to transient
depressive states while hypocortisolemia is related to chronic postpartum depression.
Discussion and Conclusion: Future research should aim to improve the accuracy of cortisol measurement over time,
obtain multiple cortisol samples in a day and utilise diagnostic measures of depression. Future studies should also
consider both antenatal and postnatal depression and the differential impact of atypical versus melancholic depression
on cortisol levels, as this can help to further clarify the relationship between perinatal depression and maternal cortisol
function across pregnancy and the postpartum period.
Keywords: Cortisol, Steroid hormones, Perinatal depression, Postpartum depression, Postnatal depression, Antenatal
depression, Maternal blues, Baby blues, Pregnancy, Maternal mood
Background
The mental health of women during the perinatal period
is affected by many factors including genetic predispos-
ition, past history of mental illness, anxious tempera-
ment, lack of family or social support and stressful life
events [1–4]. Since pregnancy brings major alterations
in the levels and function of key endocrine systems, the
role of endocrine changes across the perinatal period
has been widely investigated as an influence on maternal
mood and behaviour [5] as well as fetal and child devel-
opment [6, 7]. The current paper aims to review the lit-
erature examining cortisol functioning in relation to
perinatal depression.
Perinatal depression refers to the experience of major or
minor depressive episodes during pregnancy or within the
first 12 months postpartum. It is highly prevalent, effect-
ing 7–13 % of pregnant women and 10–15 % of women in
the six months following childbirth [8]. Furthermore, de-
pression in the perinatal period has been linked to a range
of negative outcomes such as social isolation [9], marital
discord [10], child delays in motor or intellectual develop-
ment [11], restricted fetal growth and elevated stress re-
activity in infants [12, 13]. It is particularly notable that
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vulnerability to mental health problems in later life in-
creases for infants born to mothers with postpartum de-
pression [14] and a number of mechanisms have been
proposed for this transmission [15]. More specifically,
Murray et al. (2011) report findings from a cohort study
where 41.5 % of children with depressed mothers experi-
enced depression by age 16 in comparison to 12.5 % of
children with non-depressed mothers [14].
Cortisol and the stress response
Stress plays a key role in the onset and persistence of de-
pression. Cortisol is released in response to stress and is a
key physiological marker for activation of the stress re-
sponse [16]. There has been substantial debate concerning
the role of cortisol in depression in general and specifically
during pregnancy and the postpartum [16, 17]. Cortisol is
a glucocorticoid steroid hormone, synthesized from chol-
esterol in the adrenal cortex and its release is regulated via
the hypothalamic-pituitary-adrenal (HPA) system [18].
Typically, in response to the cognitive appraisal of a sig-
nificant stressors (which can be real or imagined), cortico-
trophin releasing hormone (CRH) is produced in the
paraventricular nucleus of the hypothalamus and released
into the pituitary gland [19]. CRH then stimulates the re-
lease of adrenocorticotropic hormone (ACTH) in the an-
terior pituitary which subsequently results in the adrenal
cortex releasing a number of glucocorticoids, including
cortisol in humans [19]. The HPA axis operates in a nega-
tive feedback loop wherein cortisol release returns to
hypothalamic and hippocampal brain regions triggering
the cessation of CRH release.
In the early phases of a stressor, cortisol promotes an
adaptive response by motivating behaviours which have
high survival value such as alertness, vigilance, arousal
and attention [20]. Cortisol binds to two distinct recep-
tors whose actions regulate the duration and intensity of
the stress response. Mineralocorticoid receptors (MR) in
the limbic brain region help mediate cortisol’s response
by acting at the membrane level during the initial excita-
tory phase initiated by a stressor to determine an appro-
priate threshold for cortisol secretion and subsequently
regulate gene transcription [20]. In later phases of the
stress response, glucocorticoid receptors (GR) mediate
termination of the response, suppress information that is
unrelated to the initial stressor, and promote recovery
through mobilization of energy sources [20]. Therefore,
when cortisol secretion is sufficiently high, CRH output
is reduced, which in turn, lowers levels of pituitary
ACTH and adrenal cortisol [18].
Such a complex cascade of endocrine functions lends it-
self to numerous points of dysfunction. For instance, the
stress response can cause hypercortisolemia (an excess ex-
cretion of CRH and cortisol) [18, 21] and a substantial
body of research suggests that this excess secretion of cor-
tisol increases vulnerability to depression [22].
Cortisol in pregnancy
Given the general links between stress, cortisol and de-
pression, it is interesting to consider how pregnancy itself
interacts with maternal cortisol and in turn, increases sus-
ceptibility to depressive symptoms in the perinatal period.
First, the placenta is a major endocrine organ that pro-
duces CRH as it develops, which adds to CRH production
in the mother’s hypothalamus. Placental and hypothalamic
CRH are broadly similar in relation to their structure, bio-
activity and immune-reactivity. However, distinct from the
role of cortisol in the negative feedback system of the HPA
axis, maternal cortisol release promotes stimulation of
CRH in the placenta instead of suppressing it [19]. As a
consequence, placental CRH and cortisol in maternal
plasma increases exponentially across pregnancy and ma-
ternal levels can be 60 to 700 times higher than prior to
pregnancy [23]. In response to this high level of cortisol,
women with a well-functioning stress response become
less responsive to external stressors during pregnancy
through reduced activation of CRH neurons in the parvo-
cellular paraventricular nucleus [24]. This lowered acti-
vation is due to brainstem afferents being less effective
in stimulating CRH neurons (for physical stressors) and
altered processing of limbic structures (for emotional
stressors) during pregnancy [25]. In women with a dys-
regulated HPA axis, it is suspected that this attenuation
fails to occur and high levels of cortisol secretion com-
mon in pregnancy may then lead to hypercortisolemia
[21]. In turn, hypercortisolemia can increase a woman’s
risk of developing depressive symptoms [22], possibly
in the context of environmental stressors.
Alternatively, a second possible mechanism could be
that withdrawal from an excess level of cortisol during
pregnancy instigates depression in the postpartum due
to hypocortisolemia (where the adrenal cortex secretes
less cortisol than needed) [26]. The typical pattern of
cortisol levels commonly seen in pregnancy involves a
gradual increase, peaking at delivery and a sharp de-
cline to baseline level within the first three days post-
partum [27]. This drop not only represents the absence
of placental cortisol but also reflects a transient suppres-
sion of hypothalamic CRH. A number of researchers have
suggested that the body normally self-adjusts to this with-
drawal within the postpartum period but in cases of post-
natal depression, an over-adjustment occurs, which leads
to hypocortisolemia and triggers depressive symp-
toms [28, 29]. It is hypothesised that this relation-
ship between hypocortisolemia and maternal mood is
mediated by interactions between cortisol and the
dopaminergic systems [30–32].
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Measurement of cortisol
Cortisol in humans is secreted diurnally, with the normal
pattern being higher levels at waking, a significant increase
in cortisol concentrations 30–45 min after waking and a
subsequent decline across the remainder of the day, reach-
ing its nadir at midnight [33]. The increase after waking is
referred to as the Cortisol Awakening Response (CAR)
and is typically represented by the difference between cor-
tisol levels upon awakening and 30–45 min after waking
[34]. CAR can be measured to obtain peak cortisol levels
and an accurate representation of the diurnal pattern of
cortisol is typically obtained from measurement of mul-
tiple cortisol samples coinciding with the normal circadian
pattern across the day [33].
Cortisol can be measured through different substrates
(blood, saliva, hair, urine) and measurements of cortisol
concentrations may vary based on the substrate being
used. For example, approximately 80 % of total serum cor-
tisol is bound to cortisol-binding globulin and albumin
(plasma proteins), while free cortisol (saliva and urine) is
not protein bound [33]. Thus, one possible reason for dif-
ferences in cortisol measurements between substrates can
be attributed to changes in cortisol-binding globulin
and albumin altering serum cortisol concentrations,
without effecting free cortisol levels [35]. Furthermore,
Kirschbaum and Helhammer et al. (1989) [35] suggest
that absolute values of cortisol found in saliva are usu-
ally lower than blood serum due to an enhanced con-
version of cortisol to cortisone (an inactive metabolite)
in saliva. In terms of urine samples, Jung et al. (2014)
indicate that 24-h urine samples capture average cortisol
levels but fail to identify fluctuations in concentrations
across the day or the peaks and troughs following dosing
[36]. Overall, each substrate has a set of strengths and limi-
tations that can influence measurements of cortisol concen-
trations and the choice of substrate needs to be consistent
with the research question posed.
Aims of the current review
To our knowledge this is the first systematic review of the
literature focusing solely on studies investigating cortisol
and perinatal depression. Previous reviews have examined
selected studies, with most of these papers considering cor-
tisol in conjunction with other endocrine factors [37–43].
Kendell et al. (1985) and Wieck et al. (1989) reviewed five
studies exploring the direct relationship between cortisol
and postpartum depression, reporting results as mixed
and inconclusive. Smith et al. (1991) reviewed two
studies [44, 45] and suggested that there may be a
positive association between cortisol levels and peri-
natal depressive symptoms. Following this, Harris et al.
(1996) described three of their own studies [46–48] related
to cortisol and perinatal depression, but did not form any
conclusions. In contrast, Hendrick et al. (1998) reviewed
five [44, 46, 48–50] studies and reported no significant as-
sociation between cortisol and postpartum depression.
They also found notable confounding variables amongst
the literature and suggested that further research is re-
quired. McCoy et al. (2003) then examined two studies
[51, 52] relating to perinatal depression and CRH or corti-
sol, and found hypocortisolemia to be predictive of post-
partum depression. Similarly, Glynn et al. (2013) analysed
three studies [2, 53, 54] investigating cortisol in the post-
partum period and found lower concentrations in women
with postpartum depression, suggesting hypocortisolemia
as a related mechanism. Overall, these reviews have either
indicated no association or hypocortisolemia in postpar-
tum depression.
In this review we conducted systematic searches of the
literature in order to address a number of questions.
Firstly, to examine if there is evidence that hypercortisole-
mia predicts the onset of depression during the perinatal
period and secondly, to determine whether there is evi-
dence that hypocortisolemia instigates depressive symp-
toms in the postpartum, due to withdrawal of the placenta.
Lastly, the review aims to critically examine the method-
ology of existing studies and recommend improvements
for future research.
Method
A systematic search was conducted of 6 electronic data-
bases; MEDLINE complete, PsychINFO, SCOPUS, Science
Direct, Psychology and Behavioural Sciences, and EBSCO
up until 23/05/2015. The following search terms were
used; cortisol, postnatal depression, postpartum depres-
sion, antenatal depression, perinatal depression, depressive
disorder, depressi*, depression, pregnancy, maternal blues,
depressive symptoms (see Additional file 1 for the Scopus
search syntax). One investigator selected studies according
to the inclusion and exclusion criteria below and this se-
lection was then verified against the source by a second
investigator.
Inclusion and exclusion criteria
The review included studies presenting associations be-
tween cortisol levels and depression within the perinatal
period or postpartum blues. Perinatal depression is de-
fined as diagnosed major depression with perinatal onset,
typically measured on a validated diagnostic instrument
during pregnancy or up to one year postpartum. Postpar-
tum blues refers to a transient mood lability characterized
by mild depressive symptoms, lasting up to 14 days post-
partum. The review accepted measurement of cortisol in
any valid substrate and this included saliva, hair, urine or
blood-serum. Studies were excluded if they involved non-
human participants or focussed on paternal depression,
infant hormone levels, genetic research, and conditions
other than depression or hormones other than cortisol.
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Reviews of the literature, or studies that focused on
the theoretical underpinnings of cortisol were also not
included.
Selection of studies
There were a total of 330 papers identified from all
database searches after duplicates were removed. The
papers were initially screened through application of
the inclusion criteria to titles and then to abstracts.
As a result, 281 papers were excluded and 49 papers
remained to be considered. In a second level of screening,
full papers were reviewed and assessed against the inclu-
sion criteria, with 37 meeting the specified requirements.
A further 10 papers were found from citations within
these 37 papers and other bibliographic sources, resulting
in a total of 47 relevant papers (see Fig. 1).
Data extraction and manipulation
All three authors examined the selected papers, ex-
tracted relevant data and critically examined paper con-
tent. Effect sizes were calculated as R2 when this statistic
Fig. 1 Flowchart of systematic literature review
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was not explicitly stated in papers. The following equa-
tions were used to calculate R2:
R2 ¼ d= √ d2  þ 4  2
where d =M1 −M2/ √ SD1
2 + √ SD2
2/2 or alternatively:
R2 ¼ t2= t2 þdf 
where the t-statistic was provided [55]. In these equa-
tions, d = Cohen’s d value (standardized mean differ-
ence); M1, M2 = Mean values of the groups being
compared; SD1, SD2 = Standard deviation of the groups
being compared; t = t-test statistic, df = degrees of free-
dom. The current review did not report effect sizes for
studies with insufficient data to calculate R2.
Results
Based on the search criteria outlined above, 47 studies
were identified and are summarised in Table 1. Overall
24 studies have reported significant associations between
cortisol and depressive symptoms while another 23 did
not find significant associations. The first published
study was by Handley et al. (1977) and investigated the
association between tryptophan, cortisol and mood in 18
healthy postpartum women. Both participant mood and
hormone levels from blood plasma were measured once
daily 2–5 days postpartum between 9:00–9:30 am and
mood was identified using three self-rating scales; The
Multiple Affect Adjective Check List (MAACL), Beck
Depression Inventory (BDI) and Hildreth Feeling Scale
(used to detect elevated mood). The authors found a sig-
nificant positive relationship between cortisol and ele-
vated mood. In contrast, the same authors conducted a
second larger study [44] with 71 participants and found
that cortisol levels measured once daily at 9:00–9:30 am,
from 38 weeks gestation to 5 days postpartum, were con-
sistently higher in cases of depression than controls. How-
ever, this second study reported that seasonal variations in
plasma cortisol made it difficult to interpret their findings
as there were a significantly greater number of depressed
women during the time of year when cortisol was high.
Although these two constructs may be causally related,
this is difficult to establish [44]. After taking the seasonal
factors into account, the study reported an elevation in
cortisol only at 38 weeks gestation in women with depres-
sive symptoms.
Antenatal depression and cortisol
Out of the 24 studies that reported significant associations,
10 [56–64] identified higher cortisol levels in women with
antenatal depression than controls. Specifically, Lundy et
al. (1999) noted higher levels in women with depressive
symptoms between 27–35 weeks gestation and Field et al.
(2004; 2006; 2008) reported a positive association between
cortisol and depressive symptoms between 20–22 weeks
gestation. Likewise, Diego et al. (2009) found significantly
higher cortisol concentrations at 18–20 weeks gestation in
depressed women (identified by a structured interview)
and a positive relationship (p < 0.01) between self-reported
depressive symptoms and cortisol levels. Parcells et al.
(2010) also reported a positive relationship between self-
reported depressive symptoms and cortisol at 26–28
and 32–34 weeks gestation, but failed to find a signifi-
cant relationship between cortisol and diagnosed major
depression. Furthermore, Voegtline et al. (2013) found
that although all participants had rising cortisol levels
across 24 to 38 weeks of pregnancy, those experiencing
depressive symptoms displayed higher concentrations
between 30–32 gestational weeks. In contrast, Harris et al.
(1996) and Tsubochi et al. (2011) reported lower cortisol
concentrations in women with depressive symptoms dur-
ing the second and third trimesters of pregnancy.
Cortisol and stress reactivity
Out of the 24 studies reporting significant findings, two
studies [65, 66] used a stress challenge to examine cortisol
as an index of stress reactivity in pregnancy. Nierop et al.
(2006) administered the Trier Social Stress Test (TSST)
during 13–31 weeks gestation and saliva samples were
taken 10 min and immediately before and after the task,
with an additional five samples taken at 10, 20, 30, 45, and
60 min after the TSST. The researchers found that women
with a high risk of developing postpartum depression dis-
played greater reactivity to stressors and higher cortisol
levels. Similarly, Evans et al. (2008) ascertained stress re-
activity by administering the Stroop task (a cognitive as-
sessment of executive functioning that induces stress), a
mental arithmetic task or a controlled breathing task to
pregnant women with either no symptoms, depression,
anxiety or comorbid depression and anxiety. They ob-
tained three morning saliva samples after subjects arrived
(baseline), just before the task and directly after the task.
Evans et al. (2008) found that women with comorbid de-
pression and anxiety exhibited a greater stress response
than the other groups but there were no significant differ-
ences between controls and the group with depression
alone. The differences in results between the two studies
can be due to a range of factors, including the use of dif-
ferent stress response tasks and the gestational time tar-
geted. Furthermore, Nierop et al. (2006) measured stress
reactivity in women susceptible to depression whereas
Evans et al. (2008) based their investigation on psychi-
atric diagnoses of major depression.
Cortisol Awakening Response (CAR)
Furthermore, six studies [2, 61, 62, 67–69] investigated
the association between the cortisol awakening response
(CAR) and perinatal depression. Out of these studies,
Seth et al. BMC Pregnancy and Childbirth  (2016) 16:124 Page 5 of 19
Table 1 Summary of existing literature exploring the association between cortisol and perinatal depression
Authors Subjects: Design Measurement of cortisol (IV) Depression and stress
reactivity measure (DV)
Relevant findings
1. Handley et al.
(1977) [70]
N = 18 healthy pregnant women Cohort Study
1 sample at 4 time points: 2, 3, 4,
5 days postpartum. Time: 9–9:30 am
Blood plasma, method of
cortisol determination
unspecified
MAACL, BDI, Hildreth Feeling
Scale, the Blues Index devised
by Handley et al. (1980).
Plasma cortisol was significantly
and positively correlated with the
Hildreth Feeling scale (R2 = 0.12,
p < 0.05).
2. Handley et al.
(1980). [44]
N = 71 healthy pregnant women Longitudinal study
1 sample at 9 time points: 36,
38 weeks gestation, 1 to 5 days
postpartum, at delivery and 6 weeks
postpartum. Time: 9:00–9:30 am
Blood plasma, method of
cortisol determination not
specified.
MAACL, VAS,BDI
Global Ranking Scale
Blues Index (Handley et al.
1980)
Cortisol was higher in “cases” and
“severe cases” of depression than
non-cases from 38 weeks gestation
to 5 days post-partum. Global
Ranking Scale: R2 = 0.16, MAACL:
R2 = 0.14, VAS: R2 = 0.19, BDI:
R2 = 0.12, Blues Index = N/S.
3.Balbi et al.
(1980) [74]
N = 25 healthy pregnant women Cohort Study
4 samples at 1 time point: on 4 days
postpartum, a sample was retrieved
every 6 hours for 24 hours.
Blood plasma, RIA HAMD The depressed group (n = 6) had
significantly higher cortisol levels
than controls.
4. Kuevi et al.
(1983). [75]
N = 44 healthy pregnant women Cohort Study
1 sample from 4 time points:
2,3,4,5 days postpartum and for
N = 35, 2–3 hrs after the last breast
feed. N = 18 also had an antenatal
sample at 36 weeks gestation.
Time: 10:00 am–12:00 pm
Blood plasma, RIA A questionnaire including;
self-rating mood scale, VAS,
and questions on the frequency
and duration of crying.
No significant relationship
between mood and cortisol was
found.
5.Brinsmead et al.
(1985) [76]
N = 19 healthy pregnant women. Cohort Study
1 sample from 3 time points: 36–38th
weeks gestation, during labor, 4 days
postpartum. Time not reported
Blood plasma, RIA POMS, Caroll Depression
Inventory, a set of 5 self-rated
visual analogue scales
No significant association was
found between maternal blues
and cortisol.
6. Feksi et al.
(1984). [77]
N = 5 postpartum primiparous
women who experienced severe
blues and 5 matched mothers
who did not experience any
depressive symptoms.
Case controlled pilot study
20 samples: Samples collected at
6 am, 12 pm, 6 pm and 10 pm daily,
from day 1 to day 5 postpartum
Saliva, RIA Semi-structured interview
(Pitt, 1973).
VAS, DACL
No significant relationship
between cortisol and mood was
found.
7. Gard et al.
(1986) [49]
N = 52 healthy pregnant women Longitudinal study
1 samples at 2 time points: 36–38
weeks gestation and between 1–5
days postpartum. Time not reported.
Blood plasma, method of
cortisol determination not
specified.
MAACL, BDI, unidentified
retrospective antenatal
interview assessing mood.
No significant relationship
between cortisol and mood was
found.
8. Harris et al.
(1989) [48]
N = 147 postpartum women Cohort study
3 samples across 2 days at 6–8
weeks postpartum: between
1:30–3 pm, 10 pm and 8 am the
next day.
Saliva and blood plasma,
RIA.
EPDS, cut-off score: 12
Raskin 3 Area Depression
Rating Scales, MADRAS
No significant relationship between
cortisol and mood was found.
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Table 1 Summary of existing literature exploring the association between cortisol and perinatal depression (Continued)
9. Ehlert et al.
(1990). [71]
N = 70 postpartum women, 29
developed postpartum blues.
Longitudinal study
15 samples:
From the first day after delivery to
5 days postpartum, all women
provided 3 saliva samples daily
(8 am, 3 pm, 8 pm)
Saliva, RIA BDI
DACL
BFS (adjective checklist)
Women who experienced
postpartum blues showed
significantly higher cortisol levels
in the morning on days where
symptoms were present, in
comparison to women who did
not experience the blues
(t(59) = -2.35, p < 0.022, R2 = 0.10)
10. Smith et al.
(1990) [45]
N = 97 primiparous Australian
women (28 weeks gestation)
Divided into women whose
mood either improved (n = 46)
or deteriorated (n = 36) from
38 weeks gestation to 2 days
postpartum.
Longitudinal study
1 sample from 4 time points: 28 and
38 weeks’ gestation, during labour
and day 2 postpartum. Time: between
8–10 am.
Blood plasma, RIA POMS
MADRS
There were no significant
differences in cortisol levels
between groups (F = 1.75,
p > 0.05).
11. O’Hara et al.
(1991) [46]
N = 182 healthy pregnant women. Longitudinal study
9 time points: At 34, 36, 38 weeks;
3× blood samples daily and 24 hour
urine samples collected. 1× blood
sample daily on 1, 2,3,4,6, and 8 days
postpartum and 24 hour urine
samples on 2& 4 days postpartum.
Time: “before breakfast” On day 4
postpartum, an additional blood
sample was drawn at 4 pm.
Blood plasma and urine,
RIA
BDI, VAS, Maternal Blues Index
(Handley et al., 1980).
No significant association was
found between cortisol and mood.
12. Okano et al.
(1992). [52]
N = 47 healthy pregnant women
Attrition rate: 19 %
Longitudinal study
1 sample from 3 time points: 30–41
weeks, 3rd/4th day postpartum and
1 month postpartum. Time: 10 am
during pregnancy and 1 month
postpartum, 7 am on 3rd/4th day
postpartum.
Blood plasma, RIA Semi-structured interview
adapted from SADS
SRDS, Stein Scale for Maternity
Blues
Cortisol levels were significantly
higher 3–4 days postpartum in
the “blues” group in comparison
to those without depressive
symptoms, R2 = 0.18.
13. Pedersen et al.
(1993). [50]
N = 12 healthy pregnant women Case controlled study
I sample from 6 time-points:
38 weeks, and 1, 3, 6, 9 and 12 days
postpartum. Time not reported.
Urine and blood plasma
samples, method of cortisol
determination not specified.
VMAS, CSI
HRSD
Morning serum cortisol levels
were significantly higher 6 days
postpartum in the group with
depressive symptoms (via HRSD)
than controls (R2 = 0.08).
No significant differences in
urinary cortisol between groups
at any time point.
14. Taylor et al.
(1994) [73]
N = 163 healthy postpartum
women.
Cohort Study
1 sample, 1 time point: 3 days
postpartum. Time: 10:30 am–
12:00 pm
Blood plasma, RIA The Kennerley Blues Scale
EPDS, cut-off:10
Cortisol levels were significantly
higher in the blues group than
non-blues group (as identified by
the Kennerley Scale), R2 = 0.07.
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Table 1 Summary of existing literature exploring the association between cortisol and perinatal depression (Continued)
15. Harris et al.
(1994). [78]
N = 130 primiparous, healthy
pregnant women
Longitudinal study
Saliva: 8 am, 10 pm (2 weeks
pre-term until 35–40 days postpartum
daily) and additional 2 pm samples on
1, 2,3,4,5 days postpartum.
Blood samples: 1 sample at 2 weeks
before delivery, 1, 5, and 35 days
postpartum. Time not reported.
Saliva, RIA EPDS (did not specify cut-off
score), Stein Scale for Maternity
Blues, BDI, MADRAS.
There were no significant
associations between blues and
cortisol (neither mean
concentrations at the times of
plasma sampling nor the
decrements in concentrations
from before delivery to day 5
postpartum)
16. Mahomed
et al. (1995) [90]
N = 189 healthy pregnant,
primiparous women
Prospective study
1 sample, 1 time point (cortisol):
when in established labour. Time not
reported.
Blood plasma, RIA Pitts Depression Inventory. No significant associations
between mood and cortisol.
17.Harris et al.
(1996) [47]
N = 130 healthy pregnant,
primiparous women
Longitudinal study
Saliva: 8 am, 10 pm (2 weeks pre-term
until 35–40 days postpartum daily)
and additional 2 pm samples on 1,
2,3,4,5 days postpartum.
Blood samples: 1 sample at 2 weeks
pre-term, 1, 5, and 35 days postpartum.
Time not reported
Saliva and Blood, RIA EPDS (did not specify cut-off
score), MADRAS, Stein Scale for
Maternity Blue, Raskin 3 Area
Depression Rating Scales, a
semi-structured interview for
depression using DSM-III-R
criteria for major depression.
Depressed women had significantly
(p< 0.05) lower evening (10 pm)
cortisol on pre-natal day 14 (using
all measures), pre-natal day 1 (using
the Raskin, MADRAS and semi-
structured interview), pre-natal
days 2–7 pooled and 3 days
postpartum (using the Raskin &
MADRAS), R2 = 0.10–0.15.
18. Abou-Saleh et
al. (1998). [79]
N = 61 women (23 pregnant
women and 38 non-gravid
controls). 3 groups: postpartum
women, pregnant women and
controls.
Cross-sectional study
1 sample, 1 time point: Cortisol
measured 7 days postpartum,
between 9–10 am
Serum cortisol, RIA EPDS, cut-off score: 11
PSE
There was no significant
relationship between cortisol and
mood.
19.Lundy et al.
(1999) [56]
N = 63 pregnant women (36 with
depression)
Cortisol samples retrieved from a
subsample of 43 (25 depressed,
18 non-depressed).
Case controlled study
1 sample at 2 time points: between
27–35 weeks gestation and shortly
after term. Time: “morning hours”.
Urine (not 24 hr samples),
method of cortisol
determination not specified
CES-D, DIS Depressed mothers had
significantly higher prenatal
cortisol levels than non-depressed
mothers, F (1, 42) = 4.16, p < 0.05,
R2 = 0.03.
20. Susman et al.
(1999). [80]
N = 59 pregnant healthy
adolescents (13–19 year olds)
Longitudinal design
1 sample at 3 time points: early
pregnancy (8–16 and 9–12 weeks),
late pregnancy (32–34 weeks) and
3–4 weeks postpartum.
Time: 8:30 am.
Blood plasma, RIA DISC-2.1(administered across
all stages)
No significant relationship was
found between cortisol and
mood at any time-point.
21. Parry et al.
(2003) [53]
N = 40, 20 depressed and 20
non-depressed postpartum
women
Case controlled study
Every 30 minutes from 6 pm to
11 pm, sometime within the first
12 months postpartum.
Blood plasma, Unspecified HRDS, BD1, EPDS (did not
report cut-off score), SCID, VAS.
Hypocortisolemia was indicated
in postpartum depressed women,
in comparison to controls.
Insufficient data to obtain effect
size.
22. Field et al.
(2004) [57]
N = 140 pregnant women (70
depressed, 70 non-depressed)
1 sample at 2 time points: Average.
20.1 weeks gestation, within 24 h
following delivery. Time: “morning”
Urine samples, Unspecified CES-D Mothers with depressive
symptoms had elevated cortisol
levels in comparison to controls
at 20.1 weeks (on average).
R2 = 0.05.
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Table 1 Summary of existing literature exploring the association between cortisol and perinatal depression (Continued)
23. Diego et al.
(2004). [94]
N = 80 pregnant women, 23–27
weeks gestation
1 sample at 2 time points: 23–27
weeks gestation, within 2 weeks
postpartum. Time: 11 am–1 pm
Urine sample (not 24 hour),
RIA
CES-D Women expressing depressive
symptoms during both
pregnancy and postpartum and
only during pregnancy had
significantly higher cortisol levels
than non-depressed women
during mid gestation (R2 = 0.19,
R2 = 0.31 respectively)
24. Field et al.
(2006) [88]
N = 300 depressed pregnant
women at approx. 20 weeks
gestation
Cross-sectional study
1 sample, 1 time point: 20 weeks
gestation, Time: “first morning urine
sample”
Urine samples, RIA CES-D, SCID Cortisol significantly and
positively associated with CES-D
scores at 20 weeks gestation
(F = 6.72, p = 0.01, R2 = 0.02).
25. Nierop et al.
(2006). [65]
N = 57 healthy multiparous
pregnant women
Cross-sectional study
6 samples on a single day: Cortisol
samples were measured immediately
before and after the TSST and 10, 20,
45 and 60 minutes after testing.
Time not reported.
Saliva samples, EIA Trier Social Stress Test (TSST)
EPDS, cut-off score: 9
The group likely to develop
depression had greater
psychological reactivity to
psychosocial stress and greater
increases in cortisol levels. Cortisol
over time × group effect: F (2.41,
25.74) =2.99, p = 0.04, R2 = 0.05.
26. Groer et al.
(2007) [54]
N = 25 depressed and 175
non-depressed mothers
(at 4–6 weeks postpartum)
Case controlled study
1 sample at 1 time point: Between
4–6 weeks postpartum. Time: before
8 am for saliva and between
8–11 am for blood samples.
Saliva and blood plasma,
EIA
POMS-D Depressed mothers had
significantly lower salivary cortisol
levels than the control group
(p < .05). Serum cortisol
concentrations were not
significantly different between
groups. Insufficient data to obtain
effect size.
27. Davis et al.
(2007) [81]
N = 247 healthy pregnant women 1 sample at 4 time points: 19.1, 24.9,
30.8 weeks gestation, 8 weeks
postpartum. Time: Mean 2:20 pm,
SD: 1.5 hrs
Saliva, RIA CES-D No significant relationship
between mood and cortisol was
found.
28. Evans et al.
(2008). [66]
N = 180 pregnant women at
36 weeks gestation.
Based on psychiatric diagnosis,
4 groups were formed: n = 121
controls, 16 depressed, 34 had
anxiety, and 9 comorbid.
Case Controlled study
1 sample at 3 time points (between
33–39 weeks); upon presentation of
task (baseline), before the
psychophysiology session started
(anticipation) and after the session
(reaction). Time: 10:30–11:30 am.
Blood serum, RIA SCID, CES-D, PES
Psychophysiology task: Stroop
task, mental arithmetic task or
controlled breathing task.
Women with co-morbid depression
and anxiety had higher salivary
cortisol levels than controls
(p= 0.01). However those with
either depression or anxiety alone
did not differ significantly from
controls.
29. Field et al.
(2008) [59]
N = 430 healthy pregnant women 1 sample at 3 time points: approx.
22 and 32 weeks gestation, 2 days
postpartum. Time: “mid-morning”
Urine sample, RIA SCID, CES-D At 22 weeks gestation, depressed
women (as identified by the
SCID) had higher cortisol levels
than non-depressed women.
Insufficient data provided to
calculate effect size.
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Table 1 Summary of existing literature exploring the association between cortisol and perinatal depression (Continued)
30. Fan et al.
(2009). [87]
N = 308 pregnant or recently
delivered women.
n = 77 each in 4 groups,
representing each trimester and
1 week postpartum.
Cross-sectional study
1 sample at 3 time points: each
group (trimester), between 9–10 am
Blood/serum samples, RIA HAMD, SCL-90 No significant relationship
between cortisol and mood was
found.
31. Figueiredo et al.
(2009). [82]
N = 91 healthy pregnant,
primiparous women
Longitudinal
1 sample at 2 time points: Between
21–28 weeks and 3 months
postpartum. Time not reported
24-hour urine samples, EIA EPDS, cut-off score: 10 Cortisol was not a significant
predictor of maternal depression
32. Yim et al.
(2009). [93]
N = 100 healthy pregnant women. Longitudinal study
1 sample at 5 time points: Blood
samples were obtained at 15.3, 19.2,
25.0, 31.0 and 36.7 week’s gestation.
Time not reported.
Blood plasma, RIA CES-D, EPDS, cut-off score: 10 At no time during pregnancy
were cortisol levels associated
with concurrent depressive
symptoms or postnatal
depression (p > .53 for all
comparisons)
33. Diego et al.
(2009) [63]
N = 80 pregnant women (40
depressed, 40 non-depressed)
Longitudinal study
1 sample at 1 time point: between
18–20 weeks gestation. Time:
“mid-morning”
Urine, RIA SCID, CES-D Depressed women had
significantly higher prenatal
cortisol concentrations than non-
depressed women (determined
by the SCID & CES-D), F (1, 74)
=7.92, p = 0.006, R2 = 0.14.
34. Cheng et al.
(2010) [67]
N = 46 healthy pregnant women
at or over 36 gestational weeks.
Longitudinal
2 samples at 2 time points: 36 weeks
gestation and 4–6 weeks
postpartum. Cortisol was collected at
waking & 30 minutes after
awakening.
Saliva, method of cortisol
determination unidentified
CES-D No significant relationship
between prenatal or postnatal
CAR and CES-D scores.
35. Taylor et al.
(2009) [2]
N = 21 depressed and 30
non-depressed women at
7.5 weeks gestation
Cohort study
Samples obtained 30 min, 3 and
12 hours post-waking for 2 consecutive
days at 7.5 weeks postpartum.
Saliva, EIA EPDS, cut-off score: 13 Depressed women had a
significantly reduced morning rise
(at 30 minutes post-waking) in
cortisol concentrations than
controls, R2 = 0.34.
36. Pluess et al.
(2010). [68]
N = 66 healthy pregnant women Longitudinal study
4 time points: 35 and 36th gestation
weeks, 2 consecutive days during
10–12 weeks gestation. Samples
obtained immediately, 30, 45 and
60 minutes after waking.
Saliva, EIA EPDS, cut-off score: 13 No significant relationship
between cortisol and CAR was
found.
37. Parcells, D.A.
(2010) [60]
N = 59 healthy pregnant women Longitudinal Study
1 sample at 2 times points (cortisol):
26–28 and 32–34 weeks gestation.
Time: between 10:00–11:30 am.
Saliva, STAT Fax
2100 microplate reader
SCID,BDI-II No significant association
between SCID diagnoses and
cortisol. However, cortisol
significantly differed between
women with BDI-II scores greater
than 12 and less than 12.
Insufficient data to obtain effect
size.
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Table 1 Summary of existing literature exploring the association between cortisol and perinatal depression (Continued)
38.O’Keane et al.
(2011). [83]
N = 70 healthy pregnant women Longitudinal study
1 sample at 2 time points: 36 weeks
and 3 days postpartum. Time:
11.00 am and 3 pm.
Blood plasma, EIA EPDS, cut-off score:11
28 item Blues Questionnaire
(Kennerley & Gath, 1989)
No significant association
between cortisol and depression
(antenatal or postnatal) was
found.
39. Giesbrecht
et al. (2012) [61]
N = 83 healthy pregnant women Longitudinal Study
3 consecutive days between
6–37 weeks gestation with the
following sampling schedule; upon
waking, 30–45 min after waking and
semi-randomly with the anchor times
of 11:00 am, 4:00 pm, and 8:00 pm
Saliva, EIA POMS-15, EDPS, did not
specify cut-off score.
CAR and negative mood were
significantly associated (after
accounting for the diurnal
variations across the 3 days),
R2 = 0.29.
40. Tsubouchi
et al. (2011) [84]
N = 69 healthy pregnant women 1 sample at 5 time points: 1st
trimester (10–12 weeks), 2nd
trimester(20–22 weeks), early 3rd
trimester(30–32 weeks), late 3rd
trimester(37–39 weeks) and 1 month
postpartum. Time: between 9:00 am
and 1 pm.
Saliva, EIA. Zung self-rating depression
scale (cut off score: 42)
General Health Questionnaire
-28
Participants identified as
“chronically stressed” had lower
cortisol levels during the 2nd and
3rd trimesters than controls.
However no significant difference
was found in the 1st trimester or
postpartum. Insufficient data to
obtain effect size.
41. Salacz et al.
(2012) [89]
N = 79 pregnant women in their
36–38th gestational week
Cross-sectional study
1 sample at 1 time point: 36–38th
gestational week, before 8 am.
Blood plasma, RIA BDI-IA No significant relationship
between cortisol levels and mood
found
42. Voegtline
et al. (2013) [65]
N = 112 pregnant women between 24
and 38 weeks gestation.
Longitudinal study
1 sample at 5 time points: 24–26
weeks, 27–29 weeks, 30–32 weeks,
33–35 weeks and 36–38 weeks.
Time: between 1–3 pm.
Saliva, EIA CES-D Women who reported more
depressive symptoms between
30–32 weeks had higher cortisol
levels than controls, R2 = 0.05,
p < 0.05).
43. Peer et al.
(2013) [69]
N = 78 healthy pregnant Canadian
immigrant women
4 times per day for 2 consecutive
days at 19 weeks gestation:
immediately post-waking, 30 and
60 minutes post-waking (CAR). Time:
between 9:00 pm–10:00 pm.
Saliva, EIA EPDS, cut-off score: 12. Evening cortisol levels were
significantly higher in women
with high levels of depressive
symptoms (n = 8) than those with
low levels of depressive symptoms
(n = 45). There were no significant
differences for CAR., R2 = 0.17.
44. Shelton et al.
(2014)
N = 105 healthy pregnant women Cohort Study
1 time point: between 16 and
26 weeks gestation. Time: “before
noon” (mean time = 11:25 am).
Blood plasma, EIA POMS-D There was no significant
relationship between POMS-D
scores and cortisol, R2 = 0.02.
45. O’Connor
et al. (2014) [62]
N = 101 healthy pregnant women Longitudinal Study
CAR was measured using five
samples collected at; upon waking,
45 min, 2.5 hrs, 8 hrs and 12 hrs
post-waking.
Two CAR measurements: on average,
at 21.26 and 34.15 weeks gestation.
Saliva, EIA EPD (did not specify cut-off
scores), SCID
SCID diagnosis of depression
were significantly and negatively
associated with cortisol upon
initial waking. Insufficient data to
obtain effect size.
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Table 1 Summary of existing literature exploring the association between cortisol and perinatal depression (Continued)
46. Luiza et al.
(2015) [91]
N = 50 healthy pregnant women
recruited at approx. 11 weeks
gestation
Case-Controlled Study
1 sample at 1 time point: urine and
blood samples collected between
6–16 weeks gestation. Time: not
reported for blood samples & urine
samples were obtained “first thing in
the morning”.
Urine and Blood plasma,
EIA.
EDS, cut-off score: 11 There was no significant
relationship between cortisol and
EDS scores.
47. Shimizu et al.
(2015) [104]
N = 65 healthy Japanese
postpartum women.
Cohort study
1 sample at 2 time points: 1 month
and 4 months postpartum. Time not
reported.
Urine samples, Unspecified. EPDS (Japanese version),
cut-off score: 8-9
There was no significant
relationship between cortisol and
EPDS scores.
This table lists and provides details of existing literature examining the association between cortisol and perinatal depression
Abbreviations: BDI-IA Becks Depression Inventory revised, CSI Childcare Stress Inventory, CES-D Centre for Epidemiological Studies Depression Scale, DACL Depressive Adjective Check List, DIS Diagnostic Interview
Schedule, DISC- 2.1 Diagnostic Interview Schedule for Children, EIA enzyme immunoassay, EPDS Edinburgh Postnatal Depression Scale, EDS Edinburgh Depression Scale, HAMD Hamilton Rating Scale for Depression,
HRSD Hamilton Rating Scale for Depression, LES Life Experiences Survey, MAACL Multiple Affect Adjective Checklist, MADRAS Montgomery-Asberg Depression Rating Scale, POMS Profile of Mood States, PES Pregnancy
Experiences Scale, PSE Present State Examination, RIA radioimmunoassay, SCID Structured Clinical Inventory for DSM Disorders, SCL-90 Symptom Checklist-90, SADS Schedule for Affective Disorders and Schizophrenia,
SRDS Zung Self-rating Depression Scale, VAS Visual Analogue Scale for Mood and Anxiety, VMAS Visual Analogue Mood Scales, CAR Cortisol Awakening Response, TSST Trier Social Stress Test
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O’Connor et al. (2014) found significantly lower cortisol
levels at waking, a less sharp decline over the day and
higher average cortisol levels overall in pregnant women
with major depression. They also reported a similar but
weaker (non-significant) relationship between self-report
Edinburgh Postnatal Depression Scale (EPDS) scores and
cortisol levels. Likewise, Taylor et al. (2009) found lower
cortisol concentrations in depressed women 30 min post-
waking at 7.5 weeks postpartum. In contrast, Giesbrecht et
al. (2012) identified a significant positive relationship
between CAR and momentary mood states during 6 to
37 weeks gestation. Furthermore, three studies [67–69]
failed to find any significant relationships between CAR
and antenatal depression, with Cheng et al. (2010) reporting
neither prenatal (36 weeks gestation) nor 4–6 weeks post-
partum CAR as significantly related to perinatal depression.
Postpartum depression and cortisol
Six studies [70–74] have reported a significant positive re-
lationship between postpartum depression or depressive
symptoms and cortisol. Specifically, higher cortisol con-
centrations have been associated with depressive symp-
toms at four [74], one to five [71], three [73] and six days
postpartum. Similarly, Okano et al. (1992) also reported
significantly higher cortisol concentrations in women ex-
periencing the blues 3–4 days postpartum. They found
that cortisol levels peaked for women with and without
the blues. However, on 3–4 days postpartum, serum
levels of cortisol in controls began to decrease while
cortisol in the postpartum blues group continued to in-
crease. Overall, these results suggest that cortisol is
higher in women experiencing depressive symptoms 1–
6 days postpartum.
In contrast, numerous studies [45, 59, 67, 75–84] have
indicated insignificant associations between cortisol and
postpartum depression, while Harris et al. (1996) reported
lower cortisol concentrations in women with depressive
symptoms during the immediate postpartum period.
Likewise, recent studies such as Parry et al. (2003) and
Groer et al. (2007) have identified a significant negative
relationship between cortisol and depressive symptoms
within 12 months postpartum and 4–6 weeks postpar-
tum respectively.
Cortisol and its association with both antenatal and
postpartum depression
Harris et al. (1996) and Diego et al. (2004) were the only
studies that identified significant associations across the
antenatal and postpartum period. Harris et al. (1996) re-
cruited 130 primiparous women and found a negative
relationship between depression (as identified by a semi-
structured diagnostic interview) and evening cortisol from
2 weeks pre-term to 10 days postpartum, with effect sizes
ranging from R2 = 0.10–0.15. Similarly, Diego et al. (2004)
recruited 60 women who completed the Centre for Epi-
demiological Studies Depression Scale (CES-D), with an
equal number of participants (n = 20) in each of the fol-
lowing groups: 1) Controls 2) CES-D ≥ 16 during 23–27
weeks gestation 3) CES-D ≥ 16 at 2 weeks postpartum 4)
CES-D ≥ 16 during both the pre and postpartum period.
The results revealed that cortisol concentrations were sig-
nificantly higher in women experiencing depressive symp-
toms between 23–27 weeks gestation and women with
depressive symptoms during both the antenatal and post-
partum period, in comparison to non-depressed women.
However, the study reported a negligible effect size for the
latter finding (R2 = 0.02), with the former association pro-
ducing a moderate effect (R2 = 0.31), suggesting that this
relationship is stronger during the antenatal period.
Nevertheless, these studies have reported directly oppos-
ing findings, with Harris et al. (1996) suggesting a negative
relationship between cortisol and depression across the
perinatal period and Diego et al. (2004) indicating a posi-
tive relationship.
Critical review of methodological variation across studies
There are significant differences in findings across the
identified studies including the direction and effect of
the relationship between cortisol and perinatal depres-
sion. One potential reason for this inconsistency may be
low statistical power due to many studies including only
a small number of participants with high depressive
symptoms or diagnoses. For example, studies have based
their findings on 6 out of 25 [74], 7 out of 120, 5 out of
61 [79], 13 of 65 [69] and 16 out of 132 women experi-
encing depression or depressive symptoms [66]. Further-
more, five studies [70, 76, 77] have small overall sample
sizes of between 10 to 25 subjects.
Quality of cortisol measurements
Heterogeneous findings may also be due to the quality of
cortisol measurements. Research assessing salivary cortisol
in epidemiological studies [85] indicates that a minimum
protocol for sampling cortisol should obtain three cortisol
samples per participant across a single day, a medium
standard protocol requires six samples daily or three sam-
ples per day over three days and a high standard protocol
involves multiple samples per day across several days.
These protocols are designed to capture the curvilinear
nature of cortisol and represent a range of different stan-
dards in cortisol measurement quality [85]. Furthermore,
ideally, cortisol levels and gradients across the whole
peripartum period should be obtained. However, only
some studies have focused on gradients or trajectories
in relation to cortisol [44, 45, 72, 80, 83, 86, 87] and
most [44–46, 48–50, 54, 56, 57, 60, 63, 66, 70, 72, 73,
75, 76, 78–80, 82–84, 87–95] have not met the mini-
mum protocol, with many basing their findings on a
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single sample [54, 58, 63, 73, 79, 89–91, 95]. In addition,
participants may not adhere to sampling protocols for
urine and saliva substrates, which can reduce the reliabil-
ity of measurements.
Furthermore, the time samples are obtained can also
influence quality of cortisol samples. Out of the studies
showing significant findings, Voegtline et al. (2013) ob-
tained a single sample between 1:00 pm–3:00 pm and re-
ported an effect size of R2 = 0.05, and Pedersen et al. (1993)
obtained one sample on multiple days, did not identify
time of sample collection and reported an effect size of
R2 = 0.08. Given the diurnal characteristics of cortisol, it
is possible that single samples retrieved in the after-
noon produce underestimated cortisol concentrations
and in turn, small effect sizes. In support of this prem-
ise, it is notable that in the current review most studies
reporting larger effect sizes retrieved cortisol levels in
the morning; Handley et al. (1977), Handley et al. (1980)
gathered samples between 8:00 am–9:30 am and reported
effect sizes of R2 = 0.12 and 0.16, respectively. Similarly,
Okano et al. (1992) found an effect of R2 = 0.18 and ob-
tained cortisol levels at 7:00 am while Diego et al. (2004;
2009) measured samples between 11:00 am and 1:00 pm,
and revealed effect sizes of R2 = 0.31 and R2 = 0.14, respect-
ively. Thus, studies retrieving samples earlier in the day
may produce larger effects due to cortisol concentrations
being naturally higher during morning hours. Furthermore
many studies [47, 49, 50, 58, 65, 76, 78, 90, 91, 93] have not
identified the time of sample collection and given cortisol’s
diurnal variations, timing can create significant differences
between study findings.
In addition, studies have used different substrates, which
can cause variations in measurements of cortisol concen-
trations. For example, Groer et al.(2007) [54] found that
saliva and serum cortisol concentrations were not corre-
lated, with salivary cortisol being significantly lower than
serum in depressed women. Furthermore, different bio-
chemistry assays have been used to analyse hormones
across the studies reviewed. Some recent studies [2, 54,
61, 62, 65, 68, 69, 82–84, 91, 95] have utilised enzyme-
linked immunosorbent assay (ELISA) kits whereas the
majority [45, 46, 48, 52, 56, 59, 63, 66, 71, 73–77, 79–81,
86–90, 93, 94] have adopted radioimmunoassay (RIA)
techniques. Raff, Homar and Burns (2002) compared the
processing of salivary cortisol using ELISA kits and RIA,
and found that RIA gave results much closer to the ex-
pected value of an independently created cortisol stock
solution diluted in saliva. They suggested that salivary cor-
tisol concentrations are substantially higher using ELISA
kits, with ELISA’s over-estimating cortisol levels [96]. In
contrast, Murphy (2002) found that commercially avail-
able RIA’s yielded 2–3 times greater urinary free cortisol
than true values obtained from chromatography [97].
Thus, cortisol levels may also reflect the choice of assay,
with studies using ELISA’s for saliva samples and RIA for
urinary samples being more likely to base their results on
exaggerated cortisol concentrations.
Moreover, inter and intra assay coefficients of variabil-
ity (CV) were omitted in many studies [40, 44, 48, 49,
53, 56, 60, 65, 70, 75–78, 80, 87, 90, 94]. Typically, it is
necessary that samples run on multiple assays, where
CV’s refer to the reliability or repeatability of hormone
measurements. Thus, failing to report these values raises
uncertainty about the cortisol samples obtained. Further-
more, research [98, 99] has consistently shown that
inter-assay CVs < 15 % and intra assay CVs of < 10 % are
acceptable. However, Salacz et al. (2012) reported an
inter-assay coefficient of 16.6 % and higher than ac-
cepted inter-assay CV’s might reflect a lack of reliability
in the processing of cortisol samples.
Outcome measures
The use of different depression outcome measures and
their limitations may have contributed to the disparity in
research findings. Thirty five studies measuring depres-
sion utilised self-report questionnaires with only twelve
[47, 52, 53, 58, 60, 62, 63, 66, 77, 80, 86, 92] using semi-
structured or structured diagnostic interviews. Although
using a questionnaire to identify diagnostic status is
more time-efficient than an interview, self-report ques-
tionnaires are considerably less accurate since skilled
clinical interviewers are generally able to probe and
check the respondents answers [100]. For instance, high
scores on self-report depression scales may be due to
other health or mental health concerns than depression.
Likewise, self-report measures may confuse high levels
in a smaller clusters of symptoms as high levels of de-
pression [100]. Furthermore, studies have used different
self-report measures and those utilising the EPDS have
adopted different cut-off points for screening depression.
For example, Abou-Saleh et al. (1998), O’Keane et al.
(2011) and Luiza et al. (2015) used a score of 11 to iden-
tify participants experiencing depressive symptoms [79],
whereas Nierop et al. (2006) used scores ≥ 9 to recognise
probable cases of depression [65]. Similarly, others have
used 12 [48, 69, 101], 13 [68] or 10 [73, 93] as the differ-
entiating value and some studies [47, 53, 78] have not
reported this cut-off point at all. These differences in
cut-off scores can influence the number of depression
cases identified and interpretation of overall findings.
Moreover, only 8 studies [47, 53, 58, 60, 62, 63, 66, 92]
out of the 11 using semi-structured/structured inter-
views screened for major depression (as defined by the
DSM), with all others basing their results on reports of
maternity blues or depressive symptoms. Perinatal blues
is a mild transient lability of mood, often associated with
tearfulness and low mood [102], whereas major depres-
sion is characterized by greater severity and duration.
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Due to this difference in symptomology, comparisons
between the two conditions are difficult and study re-
sults are likely to be influenced by the construct being
measured.
Interpretation of main findings
Given the significant discrepancies between studies, it is
difficult to draw strong conclusions from these 47 studies.
One approach to the interpretation of these studies is to
give greater weight to studies with higher quality partici-
pant samples, assessment tools, cortisol samples and
greater statistical power. Based on an adaption of the Sys-
tematic Assessment of Quality in Observational Research
(SAQOR) [103], an assessment tool recently developed for
evaluating quality in psychiatry research, studies were
assessed using the following criteria: 1) whether samples
were representative of the population from which they
were drawn; 2) whether the source of participant sam-
ples was clearly stated; 3) whether participant sampling
methods were clearly described (e.g. consecutive, clin-
ical, community, convenience); 4) whether a power cal-
culation for the study’s sample size was included; 5) in
accordance with Adam and Kumari (2009), whether the
study met the minimum cortisol sampling protocol
(three samples in a day), medium sampling protocol
(six samples daily or three samples per day over three
days) or high sampling protocol (multiple samples per
day across several days) 6) if inter and intra assay CV’s
were specified and within an acceptable range 7) whether
the time cortisol samples were retrieved was reported 8)
whether a diagnostic structured/semi-structured interview
or a self-report measure with a clearly stated clinical cut-
off was used; 9) whether distorting influences such as
antidepressant exposure, other mental health disorders and
conditions that effect HPA axis function (i.e. Addison’s dis-
ease, adrenal insufficiency, Cushing’s disease, congenital
adrenal hyperplasia) were considered; 10) effect sizes. Stud-
ies were graded on each criteria and given a total score out
of a maximum score of 15. Studies were classified as high
quality if they screened positive on the majority of the cri-
teria (i.e. received a minimum score of 8), moderate if they
obtained a score of 6-7 (screened positive for 33–47 % of
the criteria) and low if they obtained a score lower than 6
(see Additional file 2).
According to this classification system, out of the stud-
ies not examining the cortisol awakening response,
Ehlert et al. (1990), O’Hara et al. (1991), Evans et al. (2008)
and Figueiredo et al. (2009) are considered high quality.
O’Hara et al. (1991) and Figueiredo et al. (2009) reported
no significant relationships between cortisol and perinatal
depression. Likewise, Evans et al. (2008) also found no
significant associations between depression alone and cor-
tisol levels before or after exposure to a psychophysiology
task during late gestation. In contrast, Ehlert et al. (1990)
identified higher cortisol concentrations in women
exhibiting depression between one to five days postpar-
tum (however, only on days when depressive symptoms
were present).
Based on these findings, the most plausible interpretation
of currently available literature is that there is not a signifi-
cant association between cortisol and antenatal depression.
However, cortisol’s role in the postpartum still remains un-
certain as Ehlert et al. (1990) reported a positive association
between cortisol and momentary maternal mood in the
immediate postpartum while O’Hara et al. (1991) and
Figueiredo et al. (2009) found no significant correlations
between cortisol and postpartum mood. This difference in
findings might be due to methodological variations be-
tween high quality studies investigating the postpartum
period. For example, Ehlert et al. (1990) measured salivary
free cortisol while O’Hara et al. (1991) and Figueiredo et al.
(2009) obtained 24 h urine samples. Furthermore, time of
sample collection, gestational period investigated and
outcome measures used differ between studies. Given
the inconsistency amongst this research and the few
high quality studies altogether, further investigation is
needed to establish if there is a relationship between
cortisol and postpartum depression.
Cortisol awakening response and maternal depression
In total, 6 studies investigated the CAR-perinatal depression
relationship, with 3 [2, 61, 62] identifying significant associ-
ations and 3 [67–69] reporting non-significance. Out of
these studies, only one study [61] is considered high quality
and reported a positive relationship between momentary
mood and concurrent cortisol levels (part of the CAR) be-
tween 6–37 weeks gestation. However, it should be noted
that all 3 studies indicating non-significant associations
recruited healthy low-risk participants with no psychiatric
disorders and measured self-reported depressive symptoms
rather than major depression. In contrast, out of the re-
search indicating significant associations, Taylor et al.
(2009) and O’Connor et al. (2014) [2, 62] focused on
depressed, high-risk participants and both studies found
lower cortisol levels upon waking in women with a diagno-
sis of depression. Based on these studies, it is suggested
that major depressive disorders (rather than maternal
blues) may be associated with a blunted cortisol re-
sponse upon waking in the perinatal period. In sup-
port, O’Connor et al. (2014) measured self-reported
depressive symptoms and diagnosis of major depres-
sion in participants but reported a significant negative
relationship only between cortisol and maternal major
depression. Thus, studies focusing on the CAR suggest
a negative association between major depression and
cortisol and a positive association between momentary
mood and concurrent cortisol levels.
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In sum, the cortisol awakening response is positively re-
lated to antenatal momentary mood states and negatively
related to major depression in the perinatal period. High
quality studies indicate a significant positive relationship
between salivary cortisol and depressive symptoms 1–5
days postpartum but non-significant relationships between
cortisol and antenatal depression. Major limitations within
low quality studies include; limited sampling occasions
and investigation of major depressive disorders, insuffi-
cient statistical power (due to low number of overall par-
ticipants and participants with depressive symptoms),
differences in substrates and method of cortisol determin-
ation between studies.
Discussion
Hypercortisolemia
The results do not indicate a positive association between
hypercortisolemia and major depression during the ante-
natal period, with higher quality studies revealing non-
significant associations between antenatal depression and
cortisol. However, out of the studies investigating CAR,
Giesbrecht et al. (2012) indicated a positive relationship
between CAR and antenatal momentary mood states. Fur-
thermore, another high quality study [71] found cortisol
secretion to be higher among women with postpartum
blues than controls. From these findings, a role for hyper-
cortisolemia in transient and momentary negative mood
states (but not major depression) seems likely.
Hypocortisolemia
Out of the eight studies investigating cortisol and postpar-
tum depression, half reported significant negative relation-
ships, [2, 47, 53, 54], while the other half [67, 81, 82, 104]
identified non-significant associations. Specifically, signifi-
cantly lower cortisol levels have been found in depressed
women at 3 days, 1 year [53] and 4–6 weeks postpartum
[54]. Taylor et al. (2009), the fourth study showing
significant results, identified a blunted CAR at 7 weeks
postpartum in women with depressive symptoms. Further-
more, Shimazu et al. (2015), reported a negative relation-
ship (although non-significant) between 1 and 3 months
postpartum and cortisol. Taken together, these studies indi-
cate an association between hypocortisolemia and depres-
sive symptoms during the postpartum period.
In addition, hypocortisolemia is typically associated
with chronic depressive states, and since the majority of
studies indicated hypocortisolemia past one month post-
partum, the results of this paper support the suggestion
that hypocortisolemia is associated with chronic depres-
sion. The only study suggesting a significant negative re-
lationship between immediate postpartum depressive
symptoms and cortisol produced a negligible effect size
(R2 = -0.0004). Thus, based on this review, chronic
depression (past 1 month postpartum) appears to be as-
sociated with hypocortisolemia.
However, the majority of studies mentioned above have
significant methodological differences and limitations, with
only two studies [2, 82] being considered high quality with
minimal flaws. In addition, two of the four non-significant
studies did not identify measurements of cortisol concen-
trations for depressed and non-depressed women, report-
ing only whether associations were significant (p < 0.05).
Therefore, meaningful findings from these studies such as
the direction and relative effect of the relationship may
have been overlooked.
Furthermore, hypocortisolemia has often been linked to
a particular subtype of depression. Specifically, studies
suggest a relationship between hypocortisolemia and atyp-
ical depression [105–107], which is defined as involving
retention of mood reactivity, weight gain, interpersonal re-
jection sensitivity, hypersomnia and depressive symptoms
that become worse as the day progresses [107]. In con-
trast, melancholic depression has been associated with
hypercortisolemia and is characterised by depressed mood
(worse in the morning), reduced appetite and/or substan-
tial weight loss, insomnia and psychomotor alterations
[107]. Most studies have not differentiated participants
with atypical and melancholic depression. This provides
another source of ambiguity and prevents a thorough ap-
praisal of the hypocortisolemia hypothesis.
Future directions
Future research should aim to include sufficient partici-
pants in their designs, report coefficients of variability for
cortisol and adhere to the minimum protocols for cortisol
sampling occasions to ensure sampling quality and meth-
odological transparency. Specifically, a minimum of three
cortisol samples across the day should be obtained to ac-
count for cortisol’s diurnal variations. Ideally however,
studies should obtain multiple cortisol samples daily and
explore patterns of cortisol trajectories (instead of concen-
trations at single time points). This will help account for
individual differences and enhance identification of differ-
ences between women with and without depression. There
are also limited studies that have measured depression
using a diagnostic tool, with most identifying depressive
symptoms or maternity blues. Therefore, further investiga-
tion into the association between diagnosed major or
minor depression in the perinatal period (as identified by a
structured or semi-structured interview) and cortisol is re-
quired. In addition, a greater number of studies investigat-
ing chronic postpartum depression (i.e. up to 12 months)
and differences in cortisol levels associated with atypical
versus melancholic depression will help in clarifying corti-
sol’s role in perinatal depression. Lastly, there is limited
published data that shows whether depression during
pregnancy differs in symptom profile from depression
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postpartum and whether either differ from depression at
other times.
Conclusions
Given the limitations identified within the research and
variations in methodology between studies, generalisations
and comparisons are difficult to make. However, the
current research indicates that: (1) hypercortisolemia may
be associated with immediate postpartum maternal blues
or antenatal momentary mood states; and (2) hypocortiso-
lemia is likely to be associated with chronic maternal de-
pressive states extending beyond one month postpartum.
Although, as already indicated, higher quality research is
required to confirm this association.
These findings are consistent with current literature that
suggests hypercortisolemia is positively linked to transient
mood lability [22]. In relation to the hypocortisolemia
finding, there are two possible explanations 1) withdrawal
of the placenta in the postpartum results in hypocortisole-
mia in women susceptible to chronic major depression
[28] 2) initial hypercortisolemia transforms over time into
hypocortisolemia during chronic stress, to protect the
brain and metabolic processes from prolonged exposure
to excess cortisol levels [108]. In support of the second hy-
pothesis, Miller et al. (2007) reviewed studies investigating
cortisol levels in a non-pregnant population experiencing
chronic stress and revealed that cortisol levels increase at
the onset of stressors but subsequently lead to hypocorti-
solemia as time passes. Miller et al. (2007) further sug-
gested that HPA functioning is influenced by a person’s
response to stress, where cortisol levels increase with the
extent of subjective distress and are reduced in those who
develop PTSD or experience significant trauma. This fur-
ther highlights that HPA axis function is dependent on
length of exposure to stress and nature of the stressor.
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